发表文章

近几年代表性文章:

Liu Y#, Yi J#, Wu P, Zhang J, Li X, Li J, Zhou L, Liu Y, Xu H, Chen E, Zhang H, Liang M, Liu P*, Pan X*, Lu Y*. Wemics: A Single‐Base Resolution Methylation Quantification Method for Enhanced Prediction of Epigenetic Regulation. Advanced Science, 2024, p.2308884.

Yu M#, Yi J#, Qiu Q#, Yao D, Li J, Yang J, Mi C, Zhou Y, Lu B, Lu W, Ying K, Chen W, Chen E, Zhang H, Lu Z*, Lu Y*, Liu P*. Pan-cancer tRNA-derived fragment CAT1 coordinates RBPMS to stabilize NOTCH2 mRNA to promote tumorigenesis. Cell Reports, 2023, 42:113408.

Hu J, Cui Z, Zhang X, Zhang J, Ge Y, Zhang H, Lu Y*, Shen D*.Uncertainty-aware refinement framework for ovarian tumor segmentation in CECT volume. Med Phys, 2023, doi: 10.1002/mp.16795.

Guo T#, Chen GQ#, Li XF#, Wang M, Liu KM, Yang XY, Liu SC, Feng YL, Liu PY*, Lin H*, Xie AY*. Small extrachromosomal circular DNA harboring targeted tumor suppressor gene mutations supports intratumor heterogeneity in mouse liver cancer induced by multiplexed CRISPR/Cas9. Genome Med, 2023, 15(1):80.

Widlansky ME#*, Liu Y#, Tumusiime S#, Hofeld B, Khan N, Aljadah M, Wang J, Anger A, Qiu Q, Therani B, Liu P, Liang M*. Coronary plaque sampling reveals molecular insights into coronary artery disease. Circ Res, 2023, 133(6):532-534.

Yi J#, Wu M#, Zheng Z, Zhou Q, Li X, Lu Y, Liu P*. Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis. J Gynecol Oncol, 2023, 34:e71.

Yang Y#, Liu H#, Liu Y#, Zhou L, Zheng X, Yue R, Mattson DL, Kidambi S, Liang M, Liu P*, Pan X*. E-value: A superior alternative to P-value and its adjustments in DNA methylation studies. Brief Bioinform, 2023, Jun 27:bbad241.

Liu Y#, Huang J#, Pandey R, Liu P, Therani B, Qiu Q, Rao S, Geurts AM, Cowley AW Jr, Greene AS, Liang M*. Robustness of single-cell RNA-seq for identifying differentially expressed genes. BMC Genomics, 2023, Jul 3;24(1):371.

Williams AC, Singh V, Liu P, Kriegel AJ. Liquid biopsies poorly mirror renal ischemia-reperfusion injury. Non-Coding RNA, 2023, 9(2):24.

Amanullah M#, Pan M#, Lu K, Pan X, Lu Y, Luo D*, Liu P*. Tumor-infiltrating immune cell landscapes in the lymph node metastasis of papillary thyroid cancer. Curr Oncol, 2023, 30 (3):2625-2641.

Cheng X, Md A, Liu W, Liu Y, Pan X, Zhang H, Xu H, Liu P*, Lu Y*. WMDS.net: a network control framework for identifying key players in transcriptome programs.  Bioinformatics, 2023, btad071.

Liu W, Yu M, Cheng S, Zhou X, Li J, Lu Y, Liu P*, Ding S*. tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer. Curr Oncol, 2023, 30(1):981-999.

Qian X, Liu P, Lu Y*. The role of non-coding RNA in tumorigenesis, development, diagnosis and treatment (in Chinese). Sci Sin Vitae, 2022, 52. doi:10.1360/SSV-2022-0087

Luo A#, Lan X#, Qiu Q#, Zhou Q, Li J, Wu M, Liu P, Zhang H, Lu B*, Lu Y*, Lu W*. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation. Cell Death & Disease, 2022, 13(11): 1-13

Yang J#, Qian X#, Qiu Q#, Xu L, Pan M, Li J, Ren J, Lu B, Qiu T, Chen E, Ying K, Zhang H, Lu Y*, Liu P*. LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis. Cell Death Dis, 2022, 13:877.

Liu Z, Zhao C*, Lu Y, Jiang Y, Yan J. Multi-scale Graph Learning for Ovarian Tumor Segmentation from CT Images. Neurocomputing, 2022, 512:398-407.

Hu J#, Wang Z#, Zuo R#, Zheng C, Lu B, Cheng X, Lu W, Zhao C, Liu P*, Lu Y*. Development of survival predictors for high-grade serous ovarian cancer based on stable radiomic features from computed tomography images. iScience. 2022, 25:104628.

Wu M#, Qiu Q#, Zhou Q#, Li J, Yang J, Zheng C, Luo A, Li X, Zhang H, Cheng X, Lu W, Liu P*, Lu B*, Lu Y*. circFBXO7/miR-96-5p/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer. Mol Cancer. 2022, 21(1):137. doi: 10.1186/s12943-022-01611-y. PMID: 35768865

Zhou L#, Qiu Q#, Zhou Q#, Li J, Yu M, Li K, Xu L, Ke X, Xu H, Lu B, Wang H, Lu W*, Liu P*, Lu Y*. Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer. Nat Commun, 2022, 13(1):1-18. doi:10.1038/s41467-022-30190-1. PMID: 35538075

Chen F, Sun C, Yue Z, Zhang Y, Xu W, Shabbir S, Zou L, Lu W, Wang W, Xie Z, Zhou L, Lu Y*, Yu J*. Screening ovarian cancers with Raman spectroscopy of blood plasma coupled with machine learning data processing. Spectrochim Acta A Mol Biomol Spectrosc, 2021, 265:120355. doi: 10.1016/j.saa.2021.120355. PMID: 34530200

Qin J, Zhang S, Poon L, Pan Z, Luo J, Yu N, Wang L, Wu X, Cheng X, Xie X, Lu Y*, Lu W*. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients. Ultrasound Obstet Gynecol, 2021, 57(5):829-839. doi: 10.1002/uog.22069. PMID: 32385928

Qian X#, Yang J#, Qiu Q#, Li X, Jiang C, Li J, Dong L, Ying K, Lu B, Chen E, Liu P*, Lu Y*. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC. J Hematol Oncol, 2021, 14(1):112.

Yue Z, Sun C, Chen F, Zhang Y, Xu W, Shabbir S, Zou L, Lu W, Wang W, Xie Z, Zhou L, Lu Y*, Yu J*. Machine learning-based LIBS spectrum analysis of human blood plasma allows ovarian cancer diagnosis. Biomedical Optics Express, 2021, 12(5):2559-2574, doi: 10.1364/BOE.421961

Qiu Q#, Zhou Q#, Luo A#, Li X, Li K, Li W, Yu M, Amanullah M, Lu B, Lu W*, Liu P*, Lu Y*. Integrated analysis of virus and host transcriptomes in cervical cancer in Asian and Western populations. Genomics, 2021, 113(3):1554-1564. doi: 10.1016/j.ygeno.2021.03.029.

Zhou L#, Wang W#, Wang F#, Yang S, Hu J, Lu B, Pan Z, Ma Y, Zheng M, Zhou L, Lei S, Song P, Liu P*, Lu W*, Lu Y*. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma. Mol Cancer, 2021, 20(1):57. doi: 10.1186/s12943-021-01352-4.

Sun X#, Yi J#, Yang J#, Han Y, Qian X, Liu Y, Li J, Lu B, Zhang J, Pan X, Liu Y, Liang M, Chen E*, Liu P*, Lu Y*. An integrated epigenomic–transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance. Theranostics, 2021;11(11): 5346-5364. doi: 10.7150/thno.58385

Pan X#, Geng X#, Liu Y, Yu M, Mishra MK, Xu X, Ding X, Liu P*, Liang M*. Transfer RNA Fragments in the Kidney in Hypertension. Hypertension, 2021, 77(5):1627-1637. doi: 10.1161/HYPERTENSIONAHA.121.16994.

Zhang Y, Liu L, Qiu Q, Ding J*, Lu Y*, Liu P*. Alternative polyadenylation: methods, mechanism, function, and role in cancer. Journal of Experimental & Clinical Cancer Research, 2021, 40(1):51. doi: 10.1186/s13046-021-01852-7.

Sun X#, Yang J#, Yu M#, Yao D, Zhou L, Li X, Qiu Q, Lin W, Lu B, Chen E, Wang P, Chen W, Tao S, Xu H, Williams A, Liu Y, Pan X, Cowley A, Jr, Lu W, Liang M, Liu P*, Lu Y*. Global identification and characterization of tRNA-derived RNA fragment landscapes across human cancers. NAR Cancer, 2020, 2(4): zcaa031.

Yu M, Lu B, Zhang J, Ding J, Liu P, Lu Y*. tRNA-derived RNA fragments in cancer: current status and future perspectives. J Hematol Oncol 13, 121 (2020). https://doi.org/10.1186/s13045-020-00955-6

Liu Y, Han Y, Zhou L, Pan X, Sun X, Liu Y, Liang M, Qin J*, Lu Y*, Liu P*. A comprehensive evaluation of computational tools to identify differential methylation regions using RRBS data. Genomics. 2020;112(6):4567-4576. doi:10.1016/j.ygeno.2020.07.032

Yao D, Sun X, Zhou L, Amanullah M, Pan X, Liu Y, Liang M, Liu P*, Lu Y*. OncotRF: an online resource for exploration of tRNA-derived fragments in human cancers. RNA Biol. 2020;17(8):1081-1091. doi:10.1080/15476286.2020.1776506.

Han Y#,Liu Y#, Zhou L#, Chen E, Liu P, Pan X*, Lu Y*. Epidemiological Assessment of Imported Coronavirus Disease 2019 (COVID-19) Cases in the Most Affected City Outside of Hubei Province, Wenzhou, China. JAMA Netw Open. 2020;3(4):e206785. Published 2020 Apr 1. doi:10.1001/jamanetworkopen.2020.6785.

Amanullah M#, Yu M#, Sun X#, Luo A, Zhou Q, Zhou L, Hou L, Wang W, Lu W, Liu P*, Lu Y*. MDEHT: a Multivariate Approach for Detecting Differential Expression of MicroRNA Isoform Data in RNA Sequencing Studies Bioinformatics. 2020 May 1;36(9):2657-2664. doi: 10.1093/bioinformatics/btaa015.

Zheng Z, Chen E, Lu W, Mouradian G, Hodges M, Liang M, Liu P*, Lu Y*. Single cell transcriptomic analysis. Compr Physiol. 2020 Mar 12;10(2):767-783. doi: 10.1002/cphy.c190037.

Liu HY#, Zhou L#, Zheng MY#, Huang J, Wan S, Zhu A, Zhang M, Dong A, Hou L, Xu H, Lu B, Lu W, Liu P*, Lu Y*. Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases. Sci Rep 9, 19365 (2019) doi:10.1038/s41598-019-55832-1.

Yang J#, Qiu Q#, Qian X, Yi J, Jiao Y, Yu M, Li X, Li J, Mi C, Zhang J, Lu B, Chen E, Liu P*, Lu Y*. Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer. Mol Cancer. 2019;18(1):171. Published 2019 Nov 29. doi:10.1186/s12943-019-1107-y

Zhang L#, Zhou Q#, Qiu Q#, Hou L, Wu M, Li J, Li X, Lu B, Cheng X, Liu P, Lu W, Lu Y*. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer. Mol Cancer. 2019;18(1):144. Published 2019 Oct 17. doi:10.1186/s12943-019-1080-5

Zheng M#, Hou L#, Ma Y#, Zhou L, Wang F, Cheng B, Wang W, Lu B, Liu P, Lu W, Lu Y*. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. Mol Cancer. 2019;18(1):76. Published 2019 Apr 2. doi:10.1186/s12943-019-0999-x

Han Y#, Yang J#, Qian X, Cheng W, Liu S, Hua X, Zhou L, Yang Y, Wu Q, Liu P*, Lu Y*. DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies. Nucleic acids research, doi:10.1093/nar/gkz096 (2019)

Lu B*, Teng X, Fu G, Bao L, Tang J, Sh H, Lu W, Lu Y*. Analysis of PD-L1 expression in trophoblastic tissues and tumors. Human pathology, 2019, 84: 202-212.

Sun X#, Han Y#, Zhou L, Chen E, Lu B, Liu Y, Pan X, Cowley AW Jr, Liang M, Wu Q, Lu Y*, Liu P*. A comprehensive evaluation of alignment software for reduced representation bisulfite sequencing data. Bioinformatics, 2018, 1: 9.

Yao D#, Zhang L#, Zheng M, Sun X, Lu Y*, Liu P*. Circ2Disease: a manually curated database of experimentally validated circRNAs in human disease. Scientific reports, 2018, 8(1): 11018.

Li X#, Li J#, Wu P, Zhou L, Lu B, Ying K, Chen E*, Lu Y*, Liu P*. Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments. Oncoimmunology, 2018, 7(10): e1494677.

Liu P*, Liu Y, Liu H, Pan X, Li Y, Usa K, M Mishra, Nie J, Liang M*. Role of DNA De Novo (De)Methylation in the Kidney in Salt-Induced Hypertension. Hypertension, 2018, 72(5): 1160-1171.

Zhang H#, Lu Y#, Chen E#, Li X, Lv B, Vikis HG, Liu P*. XRN2 promotes EMT and metastasis through regulating maturation of miR-10a. Oncogene. 2017;36(27):3925-3933.

Liu P, Iden M, Fye S, Huang YW, Hopp E, Chu C, Lu Y, Rader JS. Targeted. Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression. Cancer Epidemiol Biomarkers Prev. 2017;26(4):642-650.

Chu C, Fang Z, Hua X, Yang Y, Chen E, Cowley AW Jr, Liang M, Liu P*, Lu Y*. deGPS is a powerful tool for detecting differential expression in RNA-sequencing studies. BMC Genomics. 2015;16(1):455.

Li L, Chen E, Yang C, Zhu J, Jayaraman P, De Pons J, Kaczorowski CC, Jacob HJ, Greene AS, Hodges MR, Cowley AW Jr, Liang M, Xu H, Liu P*, Lu Y*. Improved rat genome gene prediction by integration of ESTs with RNA-Seq information. Bioinformatics. 2015;31(1):25-32.

Morrison CD#, Liu P#, Woloszynska-Read A, Zhang J, Luo W, Qin M, Bshara W, Conroy JM, Sabatini L, Vedell P, Xiong D, Liu S, Wang J, Shen H, Li Y, Omilian AR, Hill A, Head K, Guru K, Kunnev D, Leach R, Eng KH, Darlak C, Hoeflich C, Veeranki S, Glenn S, You M, Pruitt SC, Johnson CS, Trump DL. Whole Genome Sequencing Identifies Genomic Heterogeneity at a Nucleotide and Chromosomal Level in Bladder Cancer. Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):E672-81.

Kelly LM#, Barila G#, Liu P#, Evdokimova VN, Trivedi S, Panebianco F, Gandhi M, Carty SE, Hodak SP, Luo J, Dacic S, Yu YP, Nikiforova MN, Ferris RL, Altschuler DL, Nikiforov YE. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4233-8.

Wang F, Li L, Xu H, Liu Y, Yang C, Cowley AW Jr, Wang N*, Liu P*, Liang M*. Characteristics of long non-coding RNAs in the Brown Norway rat and alterations in the Dahl salt-sensitive rat. Sci Rep. 2014 Nov 21;4:7146.

Liu Y#, Liu P#, Yang C, Cowley AW Jr, Liang M. Base-Resolution Maps of 5-Methylcytosine and 5-Hydroxymethylcytosine in Dahl S Rats: Effect of Salt and Genomic Sequence. Hypertension. 2014;63(4):827-38.

Hua X, Xu H, Yang Y, Zhu J, Liu P*, Lu Y*. DrGaP: A Powerful Tool for Identifying Driver Genes and Pathways in Cancer Sequencing Studies. Am J Hum Genet. 2013 Sep 5;93(3):439-51.

Lu Y, Liu P, Van den Bergh F, Zellmer V, James M, Wen W, Grubbs CJ, Lubet RA, You M. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer. Cancer Prev Res (Phila). 2012 Feb;5(2):248-59.

Lu Y, Govindan R, Wang L, Liu PY, Goodgame B, Wen W, Sezhiyan A, Pfeifer J, Li YF, Hua X, Wang Y, Yang P, You M. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis. 2012 May;33(5):1046-54.

Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, Mills IG. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet. 2011 Jun;43(6):513-8.

Liu P, Morrison C, Wang L, Xiong D, Vedell P, Cui P, Hua X, Ding F, Lu Y, et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis. 2012;33(7):1270-6

Lu Y, Liu P, James M, Vikis HG, Liu H, Wen W, Franklin A, You M. Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor. Oncogene. 2010 Feb 18;29(7):1041-9.

Liu P, Vikis H, James M, Lu Y, Wang DL, Liu HB, et al. Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus. Cancer Res. 2009;69:6290-8.

You M#*, Wang D#, Liu P#, Vikis H#, James M,Lu Y, et al. Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res. 2009;15:2666-74.

Liu P#, Yang P#, Wu X#, Vikis HG, Lu Y, Wang Y, et al. A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Res. 2010;70:3128-35.

Liu P, Vikis HG, Wang D, Lu Y, Wang Y, Schwartz AG, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Gazdar A, Gaba C, Rothschild H, Mandal D, Coons T, Lee J, Kupert E, Seminara D, Minna J, Bailey-Wilson JE, Wu X, Spitz MR, Eisen T, Houlston RS, Amos CI, Anderson MW, You M. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst. 2008 Sep 17;100(18):1326-30.

Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, Govindan R, You M. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med. 2006 Dec;3(12):e467.

Lu Y, Yao R, Yan Y, Wang Y, Hara Y, Lubet RA, You M. A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice. Cancer Res. 2006 Feb 15;66(4):1956-63.

Liu P, Wang Y, Vikis H, Maciag A, Wang D, Lu Y, Liu Y, You M. Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat Genet. 2006 Aug;38(8):888-95.

Note: #, co-first author; *, co-corresponding author.


 

其它论文:


 

2023年文章

 


 

2022年文章

 


 

2021年文章

 


 

2020年文章

 


 

2019年文章

 


 

2018年文章

 


 

2017年文章

 


 

2016年文章

 


 

2015年文章

 


 

2014年文章

 


 

2013年文章

 


 

2012年文章

 


 

2011年文章

 


 

2010年文章

 


 

2010年以前文章